SCHEMBL7835972

SCHEMBL7835972

CCCCn1[c]nc2cnccc21

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 2/20 0.35
LMNA P02545 2/20 0.35
HPGD P15428 2/20 0.35
NPC1 O15118 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ATM Q13315 1/20 0.35
RPS6KA5 O75582 4/20 0.33
SLC9A1 P19634 1/20 0.33
MAOA P21397 4/20 0.33
MAOB P27338 4/20 0.33
ACHE P22303 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PTAFR P25105 1/20 0.32
LATS1 O95835 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5982029 0.94 MAOA (0.37) ALDH1A1KDM4ELMNAHPGDNPC1
SCHEMBL5981819 0.79 SLC9A1 (0.50) TP53MAPTSMN1; SMN2SLC9A1TDP1
SCHEMBL9228815 0.76 USP2 (0.38) ALDH1A1KDM4ELMNAHPGDNPC1
SCHEMBL5982299 0.74 ATM (0.41) ALDH1A1KDM4ELMNAHPGDNPC1
SCHEMBL5373386 0.74 SLC9A1 (0.51) ALDH1A1TP53MAPTSMN1; SMN2SLC9A1
SCHEMBL7267292 0.73 SLC9A1 (0.53) ALDH1A1TP53MAPTSMN1; SMN2SLC9A1
SCHEMBL5983792 0.73 SLC9A1 (0.53) ALDH1A1TP53MAPTSMN1; SMN2SLC9A1
SCHEMBL8484476 0.70 RPS6KA5 (0.37) ALDH1A1KDM4ELMNAHPGDNPC1
SCHEMBL7837678 0.69 ASAH1 (0.38) ALDH1A1KDM4ELMNAMAPTSLC9A1
SCHEMBL1828029 0.68 SLC9A1 (0.47) ALDH1A1KDM4ELMNAHPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0676398-B1 Heterocyclic compounds having anti-diabetic activity, their preparation and their use SANKYO CO (JP) 2001-10-24 EP disclosed
US-6117893-A Heterocyclic compounds having anti-diabetic activity and their use SANKYO COMPANY, LIMITED (JP) 2000-09-12 US disclosed
EP-1022274-A1 Oxazolidinedione and Thiazolidinedione derivatves, their preparation and their use Sankyo Company Limited (JP) 2000-07-26 EP disclosed
US-5977365-A HYPOGLYCEMIC AGENTS SANKYO COMPANY, LIMITED (JP) 1999-11-02 US disclosed
US-5624935-A ANTIDIABETIC AGENTS, HYPOGLYCEMIC AGENTS OR ANTILIPEMIC AGENTS SANKYO COMPANY, LIMITED 1997-04-29 US disclosed